Newsroom Archive
2018
HHS seeks to repurpose burn dressings for radiation emergencies
02 October 2018
HHS, Genentech join forces on medicines to combat influenza, other health security threats
01 October 2018
HHS sponsors new formulation of world’s first approved smallpox drug
25 September 2018
HHS enlists MediWound to develop treatment for sulfur mustard injury
24 September 2018
HHS partners to develop faster tests to identify bacterial infections
18 September 2018
BARDA Industry Day Lightning Talks
18 August 2018
HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections
16 July 2018
At-home influenza tests take leap forward
11 July 2018
BARDA Industry Day 2018: Save the Date
03 July 2018
Philadelphia company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
Houston company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
New York Tristate Area company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
New Orleans company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
Los Angeles company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
Greater Boston company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
Raleigh-Durham company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
Seattle-Bellevue company selected to accelerate innovation for U.S. health security, daily medical care
05 June 2018
New BARDA Funding Opportunity Announcement: BARDA Division of Research, Innovation and Ventures (DRIVe) Accelerator Network
18 April 2018
FDA approves Leukine for Acute Radiation Syndrome
29 March 2018
2017
BARDA Supports a Rapid, Deployable, Sensitive Diagnostic Platform to Diagnose Anthrax
20 November 2017
CARB-X awards Amicrobe $2.48M to accelerate the development of Amicidin-β topical antimicrobial
24 October 2017
HHS sponsors development of drug to treat infections from biowarfare agents, antibiotic-resistant bacteria
06 October 2017
HHS, Regeneron partner on portfolio of treatments for pandemic influenza, emerging infectious diseases
03 October 2017
HHS sponsors development of two tests for radiation exposure
03 October 2017
HHS pursues reusable respirator to better protect medical providers during pandemics
02 October 2017
HHS accelerates development of first Ebola vaccines and drugs
29 September 2017
HHS leverages potential respiratory drug as chemical weapon antidote
27 September 2017
HHS advances point-of-care diagnostic test for anthrax
26 September 2017
HHS partners to develop first intranasal treatment for cyanide poisoning
18 September 2017
BARDA adds new antibiotic to treat drug-resistant bacterial infections in order to protect the American public
30 August 2017
2016
Assistant Secretary Nicole Lurie announces new BARDA Director
11 November 2016
HHS pursues tests for radiation absorbed in nuclear emergency
05 October 2016
HHS sponsors commercial manufacturing tests for Ebola vaccine
04 October 2016
HHS sponsors next-generation genetic sequencing platform
30 September 2016
HHS supports next-generation anthrax vaccine into advanced development
30 September 2016
For bioterrorism preparedness, HHS sponsors inhaled chlorine antidote
29 September 2016
BARDA awards funding to speed development of Zika vaccine
26 September 2016
HHS forges strategic partnerships with two global companies to develop new antibiotics
21 September 2016
Federal prize competition seeks innovative ideas to combat antimicrobial resistance
08 September 2016
HHS accelerates development of mRNA-based Zika vaccine
07 September 2016
HHS awards $ 19.8 million to Japanese company to accelerate development of a Zika vaccine
01 September 2016
HHS awards $2.6 million to DiaSorin Group to develop rapid, high-capacity Zika diagnostic laboratory test
22 August 2016
HHS awards $5.1 million to InBios to advance Zika diagnostic
01 August 2016
HHS moves to boost Zika vaccine capacity in Brazil
24 June 2016
HHS sponsors new broad spectrum antibiotic development
20 April 2016
2015
Request for Feedback of Draft RFP for Respiratory Illness Live Virus Fill/Finish Services
20 November 2015
Pre-Solicitation: Broad Agency Announcement (BAA) for the Advanced Development of Medical Countermeasures for Pandemic Influenza
01 October 2015
HHS enhances preparedness with new products to treat severe burns
30 September 2015
HHS sponsors innovative approaches to improve influenza vaccines
30 September 2015
HHS advances development of novel drug to treat influenza
29 September 2015
HHS sponsors development of drug for hospitalized influenza Patients
28 September 2015
HHS explores new disaster use of approved “clot busting” drug
23 September 2015
HHS advances development of new monoclonal antibody drug for Ebola
21 September 2015
Experimental Ebola vaccine regimen takes new steps under HHS program
14 September 2015
Development of new anthrax vaccine underway with HHS support
17 August 2015
HHS partnership advances experimental Ebola drug
20 July 2015
Advanced Development of Broad-Spectrum Influenza Monoclonal Antibodies Request For Proposals (RFP)
19 May 2015
FDA/CDER-BARDA Innovations in Medical Countermeasure Continuous Manufacturing Request for Information
21 April 2015
BARDA Chem and RadNuc Animal Model Development RFP
06 April 2015
HHS seeks to develop improved anthrax vaccine
23 March 2015
Advanced Development of More Effective/Universal Influenza Vaccines Request for Proposals (RFP)
16 March 2015
2014
HHS supports efforts to speed Ebola vaccine delivery
23 December 2014
BARDA Chem and RadNuc Animal Model Development
05 December 2014
HHS advances development of Ebola vaccine
16 October 2014
HHS pursues detection tests for influenza
01 October 2014
HHS funds drug to treat severe infections and prevent cytokine storm
29 September 2014
HHS spurs innovation to develop next-generation portable ventilator
17 September 2014
HHS contracts with Mapp Biopharmaceutical to develop Ebola drug
02 September 2014
Ebola Experimental Treatments & Vaccines FAQ
06 August 2014
HHS establishes new network to perform clinical studies
11 March 2014
HHS funds drug for bioterrorism, antimicrobial-resistant infections
05 February 2014
2013
HHS fosters development of new blood test for anthrax
21 October 2013
HHS boosts national capacity to produce pandemic flu vaccine
30 September 2013
HHS boosts stockpile of products to treat acute radiation syndrome
26 September 2013
HHS pursues nerve agent anti-seizure drug for children and adults
25 September 2013
HHS replenishes nation’s supply of anthrax antitoxin
19 September 2013
BARDA funds study of therapy for thermal burns
17 September 2013
BARDA evaluates burn dressing for radiation, sulfur mustard burns
16 September 2013
BARDA Solicits Research Efforts for Innovative Technologies to Improve Public Health Emergency Preparedness
01 August 2013
2012 BioShield Annual Report to Congress
18 July 2013
Drug could be first against two bioterrorism threats as well as common drug-resistant infections
16 July 2013
Pre-Solicitation Notice for the Advancement of Medical Countermeasures for Pandemic Influenza
16 July 2013
BARDA Supports New Broad-Spectrum Antibiotic Drug
25 June 2013
BARDA issues Request for Proposals for Public Health and Medical Consequence Modeling Network
05 June 2013
Pre-solicitation Notice for Ancillary Acquisition to Support Pandemic Influenza Preparedness
13 May 2013
Medical Countermeasures Clinical Studies Network RFP
01 April 2013
FDA Approval of Botulism Antitoxin Heptavalent
22 March 2013
Smart DME/Power Generation RFI
18 March 2013
Request for Information Posted: Agents and/or Approaches for Treatment of New and Emerging Infectious Threats
18 March 2013
HHS Awards Contract for Advanced Development of Novel Flu Treatment
28 February 2013
BARDA Fill-Finish Manufacturing Network Solicitation posted
08 February 2013
BARDA Fill-Finish Manufacturing Network synopsis posted
23 January 2013
Statement from Assistant Secretary Nicole Lurie on FDA approval of new influenza vaccine manufactured with novel technology
17 January 2013
FDA approves new seasonal influenza vaccine
16 January 2013